Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancer CAM trials

This article was originally published in The Tan Sheet

Executive Summary

Trials studying the ability of high-dose melatonin to improve the effectiveness of radiation therapy, ginseng's utility in reducing fatigue among lung cancer radiation therapy patients and beta-hydroxy-beta-methylbutyrate's ability to increase muscle mass and quality of life in cancer patients were discussed by NIH's Cancer Advisory Panel for Complementary & Alternative Medicine at a meeting in Bethesda, Md. Dec. 13. NCI has to approve the studies before recruitment can begin; a decision is expected soon. Pharmaton's Ginsana likely will be used in the ginseng study
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS090712

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel